This was due to enhanced integrin αIIbβ3 activation of PLD2-deficient platelets under inflammatory conditions, resulting in enhanced IL-6 release of ECs to accelerate inflammation after myocardial infarction, suggesting that PLD2 is an effector of thrombo-inflammation [28]. The gene discussed is IL6; the disease is myocardial infarction.